by Bruce Oliver Newsome
New Finnish registry data finds youths referred for gender dysphoria show high psychiatric illness before and after transition, challenging claims affirmation alone resolves distress.
For years, two claims have dominated public discussion of transgender youth: distress is primarily caused by a lack of affirmation, and gender transition alleviates it.
Now, a major nationwide study from Finland refutes that narrative.
Drawing on over two decades of national registry data, the study observed every individual under 23 referred to gender identity services in Finland between 1996 and 2019. It is the most comprehensive dataset yet assembled on the treatment of gender identity.
The most robust and least controversial finding is this:
Young people referred for gender dysphoria are far more likely to have psychiatric disorders than their peers.
This elevated likelihood is large, persistent, and observable both before referral and years afterward.
Gender-referred adolescents were three times more likely than peers to show psychiatric morbidity before referral (45.7 percent vs. 15.0 percent) and four times more likely two years or more after referral (61.7 percent vs. 14.6 percent).
The U.K.’s National Health Service (NHS) defines gender dysphoria as “a sense of unease that a person may have because of a mismatch between their biological sex and their gender identity.” The NHS defines gender identity as “our sense of who we are and how we see and describe ourselves.”
With definitions as loose as these, no wonder the NHS has been a hot house of gender transition.
In December, the NHS authorized a trial of puberty blockers for 220 children.
Those are the same chemical treatments that the NHS told the Tavistock Trust to suspend in 2022, after the NHS’s own investigator, Dr. Hilary Cass, found insufficient evidence to justify their safety and prognoses . . .
Those are the same chemical treatments that Cass described as “oversold” and “built on shaky foundations” in her final report to NHS England in April 2024 . . .
Those are the same chemical treatments suspended by the conservative government of the time and the succeeding Labour government and banned indefinitely by Health Secretary Wes Streeting in December 2024 because of “unacceptable safety risks.”
Yet the NHS chose not to study those risks within the scope of the study in Finland (a country whose population is 12 times smaller).
Let’s clarify the two most important conclusions from the Finnish study.
First, gender-referred adolescents are, on average, more likely to be psychologically distressed before the referral. They do not become distressed solely because of social sanctions of their gender dysphoria or barriers to transition.
Second, gender transition increases psychological risks.
Among adolescents who underwent medical gender reassignment, psychiatric morbidity increased during follow-up—from 9.8 percent to 60.7 percent in feminizing gender reassignment and from 21.6 percent to 54.5 percent in masculinizing gender reassignment.
After adjusting for prior psychiatric treatment, gender-referred adolescents still suffer elevated rates of psychiatric morbidity, with hazard ratios approximately three times higher than non-referred females and five times higher than non-referred males.
The Finnish study is observational, not experimental. It does not prove whether gender transition improves or worsens mental health outcomes.
But it does prove that mental health difficulties are likelier for a person with gender dysphoria before any clinical intervention begins, and that the likelihood climbs again after gender transition.
This alone undermines the fashionable narrative—that distress is produced primarily by external suppression of identity and that gender transition alleviates distress.
Instead, the data suggest that broader psychiatric ill health precedes or emerges with gender dysphoria, persists despite affirmation of gender self-identity, and is made worse by gender transition.
That does not invalidate the experience of gender dysphoria. But it does refute the transgender dogmatists who push affirmation and transition on sufferers.
If you are gender dysphoric, you are not to blame. But we can blame those who pretend that affirmation and transition are the first solutions. These people are non-scientific ideologues.
The authors of the study itself do not offer that interpretation.
The data are consistent with the theory that medical transition worsens mental ill-health. Yet the authors emphasize that the same data are consistent with at least three alternative explanations:
- Increased clinical attention, i.e., once in the system, patients are more closely monitored, diagnosed, and treated.
- Severity bias, i.e., those progressing to medical intervention may already represent more severe cases.
- Long-term complexity, i.e., psychiatric conditions, often persist regardless of any single intervention.
The authors prefer to conclude that psychiatric need persists beyond gender transition, in line with count 3 above.
Personally, I find these alternative explanations comparatively trivial next to the more plausible theory that granting requests for gender transition by mentally unwell individuals caters to, rather than treats, the underlying mental illness.
My theory is consistent with the observation that treatments for military post-traumatic stress disorder (which, in a previous career, I studied in depth) that affirm externalization (“express yourself,” “let it out,” “get emotional,” “rage if you want to”) are counterproductive. They encourage people to be symptomatic, without teaching them to resolve their issues. For some patients, at least, their symptoms become worse.
The Finnish study contains findings consistent with my theory of affirmation as a cause of distress. Those referred for gender identity services after 2010 (i.e., well into the fashionable period of transgenderism) had greater psychiatric needs than earlier cohorts.
The Finnish study shatters the two main treatments offered by transgender dogmatists (including the NHS): social affirmation and medical transition.
If distress is caused socially, then social affirmation should resolve it.
But if distress is caused by a mental gender identity trapped in another gender’s body, then medical transition should resolve it.
But neither affirmation nor transition resolves the higher propensity of patients to mental ill-health.
This suggests to me that the primary response to gender dysphoria should be psychological, not social affirmation, not redressing, chemical doping, or surgery.
The Finnish findings refute the activists who claim affirmation and transition are sufficient and universal solutions.
On the other hand, the findings also challenge critics who think that the gender dysphoric will just grow out of it. Some, at least, need psychological help into adulthood, perhaps for life.
Framing matters if we are to speak to both sides without being ignored.
Both sides should be able to agree on the following conclusion:
Young people presenting with gender dysphoria are among the most psychologically vulnerable patients—and they require care that reflects that complexity.
Affirmation and transition to a non-biological gender in childhood are not sufficient care.
Bruce Oliver Newsome
Source: https://amgreatness.com/2026/04/15/the-finnish-study-that-refutes-transgender-dogma/
No comments:
Post a Comment